Clinical Trials Browser

Phase 1/2 × Prostatic Neoplasms × bicalutamide × Clear all

NCT00669162 2019-07-24

Postoperative Radiation Therapy, Hormonal Therapy and Concurrent Docetaxel for High Risk Pathologic Prostate Cancer

Phase 1/2 Completed

27 enrolled 7 charts

Prostatic Neoplasms

NCT00924807 2018-12-11

Safety Study of Sorafenib With Androgen Deprivation and Radiotherapy to Treat Prostate Cancer

Phase 1/2 Terminated

4 enrolled 4 charts

Prostatic Neoplasms

NCT00075192 2012-06-06

CP-675,206 With Neoadjuvant Hormone Therapy in Patients With High Risk Prostate Cancer

Phase 1/2 Completed

Prostatic Neoplasms